KALA BIO INC(NASDAQ:KALA) stock News

KALA Latest News, Press Relases and Analysis

All

Press Releases

13 hours ago - By: Benzinga - Mentions: SPY DNA QQQ SNGX ...

5 Healthcare Stocks On Fire This Week

8 days ago - By: Zacks Investment Research

Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade

14 days ago - By: The Motley Fool

Kala Bio (KALA) Q2 Loss Widens 15%

14 days ago - By: KALA BIO, Inc.

KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update

14 days ago - By: KALA BIO, Inc.

KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update

a year ago - By: BusinessInsider

KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024

a year ago - By: InvestorPlace

KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024

a year ago - By: BusinessInsider

KALA Stock Earnings: Kala Pharmaceuticals Misses EPS for Q1 2024

16 days ago - By: KALA BIO, Inc.

KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

16 days ago - By: KALA BIO, Inc.

KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

a month ago - By: Benzinga - Mentions: JHX SOFI HROW JANX

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

a month ago - By: KALA BIO, Inc.

KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

a month ago - By: KALA BIO, Inc.

KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

2 months ago - By: KALA BIO, Inc.

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

3 months ago - By: KALA BIO, Inc.

KALA BIO to Present at Jefferies Global Healthcare Conference

3 months ago - By: KALA BIO, Inc.

KALA BIO to Present at Jefferies Global Healthcare Conference

3 months ago - By: KALA BIO, Inc.

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: KALA BIO, Inc.

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update

5 months ago - By: KALA BIO, Inc.

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

5 months ago - By: KALA BIO, Inc.

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

6 months ago - By: KALA BIO, Inc.

KALA BIO to Present at TD Cowen 45th Annual Health Care Conference

6 months ago - By: KALA BIO, Inc.

KALA BIO Announces Chief Executive Officer Transition

6 months ago - By: KALA BIO, Inc.

KALA BIO Announces Chief Executive Officer Transition

8 months ago - By: KALA BIO, Inc.

KALA BIO Announces $10,750,000 Private Placement

8 months ago - By: KALA BIO, Inc.

KALA BIO Announces $10,750,000 Private Placement

9 months ago - By: KALA BIO, Inc.

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

9 months ago - By: KALA BIO, Inc.

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

9 months ago - By: KALA BIO, Inc.